Literature DB >> 10961610

Detection of early HIV infection and estimation of incidence using a sensitive/less-sensitive enzyme immunoassay testing strategy at anonymous counseling and testing sites in San Francisco.

W McFarland1, M P Busch, T A Kellogg, B D Rawal, G A Satten, M H Katz, J Dilley, R S Janssen.   

Abstract

Timely estimates of HIV incidence are needed to monitor the epidemic and target primary prevention but have been difficult to obtain. We applied a sensitive/ less-sensitive (S/LS) enzyme immunoassay (EIA) testing strategy to stored HIV-positive sera (N = 452) to identify early infections, estimate incidence, and characterize correlates of recent seroconversion among persons seeking anonymous HIV testing in San Francisco from 1996 to 1998 (N = 21,292). Sera positive on a sensitive EIA but negative on a less-sensitive EIA were classified as early HIV infections; sera positive on both EIA were classified as long standing. Seventy-nine sera were from people with early HIV infection. Estimated HIV incidence was 1.1% per year (95% confidence interval [CI], 0.68%-1.6%) overall and 1.9% per year (95% CI, 1.2%-3.0%) among men who have sex with men (MSM). Early HIV infection among MSM was associated with injection drug use, unprotected receptive anal sex, and multiple sex partners in the previous year. No temporal trend in HIV incidence was noted over the study period. The S/LS strategy provides a practical public health tool to identify early HIV infection and estimate HIV incidence in a variety of study designs and settings.

Entities:  

Mesh:

Year:  1999        PMID: 10961610     DOI: 10.1097/00126334-199912150-00009

Source DB:  PubMed          Journal:  J Acquir Immune Defic Syndr        ISSN: 1525-4135            Impact factor:   3.731


  18 in total

1.  Impact of highly active antiretroviral treatment on HIV seroincidence among men who have sex with men: San Francisco.

Authors:  Mitchell H Katz; Sandra K Schwarcz; Timothy A Kellogg; Jeffrey D Klausner; James W Dilley; Steven Gibson; William McFarland
Journal:  Am J Public Health       Date:  2002-03       Impact factor: 9.308

2.  The continuing HIV epidemic among men who have sex with men.

Authors:  J A Catania; D Osmond; R D Stall; L Pollack; J P Paul; S Blower; D Binson; J A Canchola; T C Mills; L Fisher; K H Choi; T Porco; C Turner; J Blair; J Henne; L L Bye; T J Coates
Journal:  Am J Public Health       Date:  2001-06       Impact factor: 9.308

3.  HIV in the United States at the turn of the century: an epidemic in transition.

Authors:  J M Karon; P L Fleming; R W Steketee; K M De Cock
Journal:  Am J Public Health       Date:  2001-07       Impact factor: 9.308

4.  HIV incidence among injection drug users in New York City, 1990 to 2002: use of serologic test algorithm to assess expansion of HIV prevention services.

Authors:  Don C Des Jarlais; Theresa Perlis; Kamyar Arasteh; Lucia V Torian; Sara Beatrice; Judith Milliken; Donna Mildvan; Stanley Yancovitz; Samuel R Friedman
Journal:  Am J Public Health       Date:  2005-06-28       Impact factor: 9.308

5.  Seroincidence of recent human immunodeficiency virus type 1 infections in China.

Authors:  Yao Xiao; Yan Jiang; Jigang Feng; Wenyan Xu; Minjie Wang; Ellen Funkhouser; Sten H Vermund; Yujiang Jia
Journal:  Clin Vaccine Immunol       Date:  2007-08-01

6.  Condom use at last sex as a proxy for other measures of condom use: is it good enough?

Authors:  Sinead N Younge; Laura F Salazar; Richard F Crosby; Ralph J DiClemente; Gina M Wingood; Eve Rose
Journal:  Adolescence       Date:  2008

7.  Precision and accuracy of a procedure for detecting recent human immunodeficiency virus infections by calculating the antibody avidity index by an automated immunoassay-based method.

Authors:  Barbara Suligoi; Claudio Galli; Mario Massi; Fiorella Di Sora; Mauro Sciandra; Patrizio Pezzotti; Olga Recchia; Francesco Montella; Alessandro Sinicco; Giovanni Rezza
Journal:  J Clin Microbiol       Date:  2002-11       Impact factor: 5.948

8.  Rate and incidence estimates of recent human immunodeficiency virus type 1 infections among pregnant women in Sao Paulo, Brazil, from 1991 to 2002.

Authors:  Carmem A de Freitas Oliveira; Mirthes Ueda; Rosemeire Yamashiro; Rosângela Rodrigues; Haynes W Sheppard; Luís Fernando de Macedo Brígido
Journal:  J Clin Microbiol       Date:  2005-03       Impact factor: 5.948

Review 9.  The potential role of biomarkers in HIV preventive vaccine trials.

Authors:  Ellen Maclachlan; Kenneth H Mayer; Ruanne Barnabas; Jorge Sanchez; Beryl Koblin; Ann Duerr
Journal:  J Acquir Immune Defic Syndr       Date:  2009-08-15       Impact factor: 3.731

10.  Comparison of the human immunodeficiency virus (HIV) type 1-specific immunoglobulin G capture enzyme-linked immunosorbent assay and the avidity index method for identification of recent HIV infections.

Authors:  Stephan Loschen; Jörg Bätzing-Feigenbaum; Gabriele Poggensee; Christiane Cordes; Bettina Hintsche; Michael Rausch; Stephan Dupke; Silvia Gohlke-Micknis; Jana Rödig; Osamah Hamouda; Claudia Kücherer
Journal:  J Clin Microbiol       Date:  2007-10-31       Impact factor: 5.948

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.